ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

TSTL Tristel Plc

462.50
7.50 (1.65%)
24 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Tristel Plc LSE:TSTL London Ordinary Share GB00B07RVT99 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  7.50 1.65% 462.50 455.00 470.00 462.50 455.00 455.00 41,048 14:06:06
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Med, Dental, Hosp Eq-whsl 36.01M 4.46M 0.0941 49.15 219.23M
Tristel Plc is listed in the Med, Dental, Hosp Eq-whsl sector of the London Stock Exchange with ticker TSTL. The last closing price for Tristel was 455p. Over the last year, Tristel shares have traded in a share price range of 327.50p to 499.00p.

Tristel currently has 47,400,993 shares in issue. The market capitalisation of Tristel is £219.23 million. Tristel has a price to earnings ratio (PE ratio) of 49.15.

Tristel Share Discussion Threads

Showing 3051 to 3074 of 4000 messages
Chat Pages: Latest  124  123  122  121  120  119  118  117  116  115  114  113  Older
DateSubjectAuthorDiscuss
19/2/2018
13:38
Ecomed SA/NV @EcomedSANV Tristel Duo Ultrasound
wordt Tristel Duo ULT: enkel een nieuw jasje, aan de inhoud
en de werking verandert niets! @TristelGlobal #highleveldes
infectie #chloordioxide #30Seconden #infectiepreventie

Translated from Dutch by Microsoft
Tristel Duo Ultrasound becomes Tristel duo ULT: Just a
new jacket, to the content and operation nothing changes!
@TristelGlobal #highleveldesinfectie #chloordioxide #30
Seconden #infectiepreventie


- where are they going with these name changes?
- knock off the ULT > Tristel Duo?

piedro
16/2/2018
10:36
Thank you for your offer Glaws2.

I do have some questions on product development ...
- how much is being spent on product development and marketing?
- what percentage reaches the market?
- and of the new products, how many are successful?

The reason for asking is that ...

Known products under development:
'Revolver' is no longer mentioned and now there is 'Puffin'

Products launched but seemingly discontinued:
Shine - Washer disinfector
Legion - disinfecting and descaling foam
Dental products: Dentel Duo / Dentel 100 / Dentel 5
Baby Products: Protect sporicidal foam / Protect bactericidal wipes
Tristel Life: 5 / Foam / Wipes system

piedro
16/2/2018
09:39
Piedro

Any idea why so much interest in tristel from Bolivia?
biggest number of non UK visits to the site

cameronm
16/2/2018
07:05
It's quiet at the moment as we are all waiting for next week's interims. I'm going to the presentation of you want any questions asked Piedro.
glaws2
15/2/2018
10:17
FYI,

You may have noticed the "Visitors counter" {by FlagCounter.com} in the header.
- I find it useful by reason of the fact that although I am sometimes the only person contributing, there have been for example, 670 odd pageviews in the last 30 days.
- from all parts



- please feel free to express your opinions, for better or for worse; I have it on good authority that members of the company do look in from time to time.

Best regards,:-)

Piedro

piedro
13/2/2018
14:06
The original 'Research Article' is well worth reading being well balanced regarding the results and also mentions the economics of each method

- there were 5 positive cultures found on post-decontamination swabs, 2 of which were from non-contaminated swabs !!
- which somewhat reduces the credibility of the study IMO

"We believe the positive cultures post decontamination are likely due to improper handling of the nasoendoscopes post decontamination rather than a result of inadequate disinfection."

piedro
13/2/2018
13:07
Original Research Article
Flexible nasoendoscopy decontamination: a comparison between Rapicide and Tristel wipes, a prospective cohort study
Yijin Jereme Gan, Alex Mathews, Phua Chuqin, Ivan Khoo, David Loke

piedro
13/2/2018
12:11
The post-decontamination swab culture results were four positive culture swabs for those disinfected with Tristel Wipes and one positive culture swab for Rapicide cohort. The efficacy of Rapicide was 98.8% compared to 94.7% for Tristel.

After statistical analysis, the difference between either was not considered to be statistically significant.

The study also noted that the positive cultures post-decontamination were likely due to improper handling of the nasoendoscopes rather than a result of inadequate disinfection.

In conclusion, the study validated the efficacy of Tristel Wipes as a comparable alternative to peracetic acid-based disinfectants for flexible nasoendoscopes. The study also concluded that Tristel is a more convenient, faster, more
portable and more ergonomic alternative to Rapicide.

- wonderful thing 'statistical analysis' !!!
- 4 vs 1 = no difference

piedro
13/2/2018
11:56
Found on twitter ...

Tristel Global@TristelGlobal
Introducing Tristel Science
First paper: Study concludes that chlorinedioxide wipes have equivalent efficacy to a world-leading peraceticacid high-level disinfectant and provide significant other advantages to hospitals.





- it is as though they did not want this to been seen!
- and take us for idiots
- website becoming convoluted again

AIMHO, BWDIK ...

piedro
10/2/2018
12:23
I'm looking forward to Q2 results in 10 days time and hoping for positive news regards their progress with the EPA application for approval although it may be a little early for that since the update in December. The interim dividend announcement should also be interesting; I expect a small increase but that may be optimistic if the company is seeking to build a big war chest to exploit US opportunities when (if?) that comes.

I'm considering topping up ahead of results, especially if there is another dip down. Any similar thoughts out there?

zimbtrader
09/2/2018
10:21
Glaws2 - thank you, I have found the reference

I use ShareScope but find it quite inadequate for Major Holdings and Directors Dealings

from the Annual Reports:

..Date.........Shares
30-09-12.... 1,388,515... 3.47%
30-09-16.... 1,315,638... 3.11%
30-06-17.... 1,936,122... 4.53%
and the latest RNS
07-02-18.... 2,149,337... 5.00%

piedro
09/2/2018
06:09
Piedro - I lifted the information from Sharepad
glaws2
08/2/2018
14:59
Thank you Glaws.
I do not have any record of a previous Investec holding - can you tell me when it happened ?

piedro
08/2/2018
14:28
Investec have gone upto 5% - previously they had 4.5%
glaws2
08/2/2018
14:21
Investec Wealth & Investment Limited bought 5%. Any significance?
ashehzi
25/1/2018
07:57
Vesismin Health @Vesismin
Desinfección de Alto Nivel de sondas invasivas:



- in Spanish but worth a read

piedro
24/1/2018
07:09
Today's RNS -

Study shows comparable efficacy of Tristel Wipes

Tristel's chlorine dioxide wipes are validated as a viable alternative to peracetic acid disinfectants for the high-level disinfection of flexible nasendoscopes

Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces that a study conducted at the Khoo Tech Puat Hospital, Singapore, has concluded that the Tristel Wipe has comparable efficacy to a world leading peracetic acid high-level disinfectant (Rapicide; Cantel Medical, New Jersey, USA), and provides significant other advantages to a hospital.

The study has been published in the International Journal of Otorhinolaryngology and Head and Neck Surgery (Gan YJ et al. Int J. Otorhinolaryngol Head Neck Surg. 2018 Jan; 4(1):18-23). Cantel is one of the world's largest dedicated infection prevention companies quoted on the NYSE.

The study took place in the Ear, Nose and Throat clinic during 2014. One hundred patients volunteered to participate and for each endoscopic examination one nasendoscope disinfected by Rapicide and one nasendoscope disinfected by a Tristel Wipe was used to scope each nasal passage of the patient. From swabbing each nasendoscope pre and post disinfection to reveal evidence of bacterial contamination the study concludes that Rapicide and the Tristel Wipe are statistically equivalent in terms of efficacy.

In addition to being comparable with Rapicide the study identifies other significant advantages of the Tristel Wipe. These benefits are rapid turnaround of the nasendoscope (2-3 minutes for Tristel versus 20 minutes for Rapicide) which means the clinic can see more patients in a day with fewer nasendoscopes; Tristel's safety from a health standpoint, and the Tristel Wipe's portability which means that it can be easily taken to the emergency department or to the wards. This is important as even though most ENT departments are out-patient areas, frequently in-patients carry MRSA, vancomycin-resistant Enterococci (VRE), and even tuberculosis, and need to have a nasendoscopy. The Tristel Wipe can easily be taken to them to enable the examination.

The Tristel Wipes System is a unique, patented decontamination method for non-lumened endoscopes and ultrasound probes. It has been a very significant sales success for the Company globally. Worldwide sales of the Wipes System in the financial year ending June 2017 were £11.5m.

Paul Swinney, CEO, comments: "We are pleased to see the publication in a peer-reviewed journal of yet another study comparing our Wipe with a leading peracetic acid high-level disinfectant - Cantel's Rapicide product. Peracetic acid is the most widely used high-level disinfectant chemistry in Europe and probably the United States also. The results affirm the key advantages of our Wipes over alternative chemistries and disinfection methods. These advantages are the level and speed of kill and the capability of our Wipe System to be deployed anywhere within a healthcare setting without the need for power, water and space. This is the thirty first peer-reviewed and published scientific paper featuring Tristel products - a body of evidence of our products' attributes that forms one of our Company's key strengths."

metis20
17/1/2018
10:00
Sorry Piedro - the comment was in jest as I know full well Liz (who I have met many times) is the board FD; I just thought Oakley was inflating his role.
glaws2
17/1/2018
09:39
Liz Dixon - Chief Financial Officer



Joined in July 2007


Glaws2,

- Paul Oakley may be Finance Director but not a member of the BoD

- from website
Board of Directors
Francisco Soler
Paul Swinney
Liz Dixon
Paul Barnes
David Orr
Tom Jenkins

piedro
17/1/2018
09:08
Paul Oakley - Finance Director at Tristel Solutions and Group Head of Finance



Joined in June 2010
- I have been involved in and been the lead on operating system implementations. The most recent, being the lead on a group wide roll-out of SAP Business One, on HANA, the roll-out included the UK, Germany, New Zealand, Hong Kong and China.

- Through my roles I have produced and now oversee the production of monthly management accounts but also monthly business wide reporting. Cashflow, Treasury management, payroll and HR are overseen by myself and the I.T department reports. The production of year end accounts and seeing them through successful audits are my responsibility also
[Source: LinkedIn]

piedro
17/1/2018
08:52
Tim Newton - Head of Global IT & Systems at Tristel plc



Joined in August 2014
Manage and maintain all aspects of the IT for over 100 users across 4 branches globally which include Newmarket, Berlin, Shanghai, Tauranga (New Zealand).
• Worldwide roll out of SAP Business One Hana (ERP system) for 4 branches with zero downtime and impact to the daily running of the business.
... ...
[Source: LinkedIn]

- it has taken him 3½ yrs to roll out the system !!

piedro
17/1/2018
07:43
New finance director there !
glaws2
17/1/2018
00:49
It's nothing to do with the share price or the accounts
It's about what makes the company 'tick'

:-)

piedro
17/1/2018
00:42
Tristel cleans up its approach to data with SAP Business One and Codestone
SAP Business One
Published on 1 Nov 2017
Tristel manufactures infection and contamination control products for medical instruments and surfaces in hospitals, veterinary practices and cosmetic and pharmaceutical companies. Tristel was struggling to consolidate data from multiple branches, which created inconsistencies across the business. It chose SAP Business One for its flexibility, multi-language support and intuitive user interface. Now it can connect all of its entities worldwide, with real-time visibility into operations and finances, which enables head office to be more supportive and collaborative. As Tristel grows and develops new markets and entities, it has confidence that SAP Business One will grow side-by-side.

piedro
Chat Pages: Latest  124  123  122  121  120  119  118  117  116  115  114  113  Older

Your Recent History

Delayed Upgrade Clock